NCT06406062

Brief Summary

In recent years, computer-aided diagnosis system based on artificial intelligence (AI) has been used in colorectal polyp detection. In recent years, computer-aided diagnosis system based on artificial intelligence (AI) has been used in colorectal polyp detection. However, whether AI-assisted can improve the adenoma-detection rate (ADR) is inconclusive. This study aims to evaluate the real-world performance of an AI system that combines polyp detection with colonoscopy quality control. This study aims to explore the clinical application value of AI-based polyp detection and quality control function by comparing the data of polyp detection rate and adenoma detection rate in multiple centers with and without AI-assisted colonoscopy in a multicenter, prospective real world study. However, whether AI-assisted can improve the adenoma-detection rate (ADR) is inconclusive. This study aims to evaluate the real-world performance of an AI system that combines polyp detection with colonoscopy quality control. This study aims to explore the clinical application value of AI-based polyp detection and quality control function by comparing the data of polyp detection rate and adenoma detection rate in multiple centers with and without AI-assisted colonoscopy in a multicenter, prospective real world study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
7,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 9, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

May 20, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

April 13, 2025

Status Verified

April 1, 2025

Enrollment Period

1.6 years

First QC Date

April 25, 2024

Last Update Submit

April 9, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adenoma detection rate

    The numerator is the number of patients who had at least one adenoma on colonoscopy, and the denominator is the total number of patients who underwent colonoscopy

    During Endoscopy procesure

Secondary Outcomes (5)

  • Polyp detection rate

    During Endoscopy procesure

  • Detection rate of serrated adenoma

    During Endoscopy procesure

  • Average number of polyps per colonoscopy

    During Endoscopy procesure

  • Colonoscopy time

    During Endoscopy procesure

  • Proportion of over-speed frames

    During Endoscopy procesure

Study Arms (2)

AI-assisted group

Group with AI assistance

Device: ANDOANGEL

Control group

Group without AI assistance

Interventions

ANDOANGELDEVICE

Polyps were identified by endoscopists assisted by an AI system: rectangular box marks; Monitoring of ileocecal position: whether blindness was reached was displayed in the lower left corner of the interface. Mirror entry and exit time monitoring: the operation time is displayed in the upper left corner of the interface. Colonoscopy withdrawal speed monitoring: the relative withdrawal speed was displayed on the left side of the interface.

AI-assisted group

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients required diagnostic colonoscopy, screening colonoscopy, or follow-up colonoscopy

You may qualify if:

  • age \> 50 years old;
  • required diagnostic colonoscopy, screening colonoscopy, or follow-up colonoscopy;
  • voluntarily sign informed consent;
  • Commitment to abide by the study procedures and cooperate with the implementation of the whole process of the study.

You may not qualify if:

  • have participated in other clinical trials, signed informed consent and are in the follow-up period of other clinical trials;
  • known polyposis syndrome patients;
  • patients with known IBD;
  • patients considered by the investigators to be unsuitable or unable to undergo complete digestive endoscopy and related examinations;
  • high-risk diseases or other special conditions considered by the investigator to be unsuitable for clinical trial participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renmin Hospital of Wuhan Univercity

Wuhan, Hubei, 430060, China

RECRUITING

Central Study Contacts

Honggang Yu, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2024

First Posted

May 9, 2024

Study Start

May 20, 2024

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

April 13, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations